New research from scientists at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) determined that a particular gene—MDA-9/Syntenin-1/SDCBP—is the ringleader behind a molecular domino effect driving prostate cancer growth and metastasis. The findings could hold significant clinical implications for the treatment of prostate cancer and other forms of disease.
Leave A Comment